FIELD: pharmaceutics; urology.
SUBSTANCE: group of present inventions relates to the field of pharmaceutics, namely to urology, and it is the use of Copaifera oleoresin as a medical product intended for the treatment or prevention of benign prostatic hyperplasia, where Copaifera is selected from C. officinalis and C. multijuga. The group of inventions also relates to a pharmaceutical composition for the treatment or prevention of benign prostatic hyperplasia.
EFFECT: expansion of the arsenal of means of specific purpose.
4 cl, 5 tbl, 4 ex
Authors
Dates
2022-05-31—Published
2018-03-20—Filed